R&D Center for Blood Products_R&D Platforms_Innovation_中国生物技术股份有限公司

R&D Center for Blood Products

The China Biological Blood Products R&D Center was established in 2018, with blood products and recombinant blood products as its core task, specializing in immunoglobulins, blood-derived coagulation factors, enzymes and enzyme inhibitors, recombinant coagulation factors, etc. Product development. The R&D center adheres to the philosophy of “Caring for Life and Care for Health” of China Biology, integrates internal and external resources of China Biology’s blood production segment, concentrates the scientific research superior resources of each subsidiary, reduces repeated R&D investment, and pays attention to the research and development of rare disease treatments and orphan drugs, and accelerates To achieve the listing of key products and continue to promote technological progress and product innovation in China's blood products industry.